An expert-approved guide to a multitasking cosmetic with a wide range of benefits — from clearing congested pores to reducing the appearance of wrinkles.

Treat your eczema by partnering with a board-certified dermatologist. You might need to change your treatment plan, depending ...

Learn about various topical treatments for joint pain in rheumatoid arthritis. Discover options like NSAIDs, capsaicin, and ...

The approval was based on the TRuE-AD3 trial, which evaluated the safety and efficacy of ruxolitinib in pediatric patients aged 2 to 11 years with atopic dermatitis.

Layering sunscreen and moisturizer in the proper order can ensure that you achieve the benefits that each product is intended to provide.

But where to start? The most medically sound and impartial way is through the advice of a dermatologist. In this case, New York City-based board-certified dermatologist, Dr. Rachel Nazarian, MD, FAAD, ...

WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) cream 1.5% for children as young as two with mild to moderate ...

Men are embracing skinimalism, hydration, and stress recovery as part of a smarter skincare routine that actually fits their ...

Patients with onychomycosis who are treated with topical urea 40% in addition to antifungal therapy may have improved clinical cure rates.

If you are experiencing dryness, irritation, or underwhelming results from your hypochlorous acid, these rookie mistakes ...

The US Food and Drug Administration has approved Opzelura cream 1.5 percent (ruxolitinib) for children ages 2 to 11 years with atopic dermatitis (AD).